Correlation Between Design Therapeutics and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Lyell Immunopharma, you can compare the effects of market volatilities on Design Therapeutics and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Lyell Immunopharma.
Diversification Opportunities for Design Therapeutics and Lyell Immunopharma
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Design and Lyell is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Design Therapeutics and Lyell Immunopharma
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.93 times more return on investment than Lyell Immunopharma. However, Design Therapeutics is 1.08 times less risky than Lyell Immunopharma. It trades about 0.01 of its potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.01 per unit of risk. If you would invest 1,350 in Design Therapeutics on August 27, 2024 and sell it today you would lose (788.00) from holding Design Therapeutics or give up 58.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Design Therapeutics vs. Lyell Immunopharma
Performance |
Timeline |
Design Therapeutics |
Lyell Immunopharma |
Design Therapeutics and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Lyell Immunopharma
The main advantage of trading using opposite Design Therapeutics and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Lyell Immunopharma vs. Eliem Therapeutics | Lyell Immunopharma vs. HCW Biologics | Lyell Immunopharma vs. Scpharmaceuticals | Lyell Immunopharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |